Pricing Log in Create free account

Nuvectis Pharma, Inc. (NVCT) vs Solid Biosciences Inc. (SLDB)

Nuvectis Pharma, Inc. and Solid Biosciences Inc. are both Biotechnology companies. Nuvectis Pharma, Inc. and Solid Biosciences Inc. are of similar size ($618.0M and $615.5M). Across the 8 metrics below, Solid Biosciences Inc. leads on 6 and Nuvectis Pharma, Inc. on 2.

Valuation

Metric NVCT SLDB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 70.64 9.71
P/B 47.77 2.12 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 37.04 9.21
Earnings yield (7.09%) (34.54%) (33.15%)
Free cash flow yield (4.50%) (23.62%) (25.50%)

Profitability

Metric NVCT SLDB Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (233.30%) (65.50%) (56.36%)
Return on assets (122.61%) (56.83%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NVCT SLDB Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (18.92%) 34.97% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NVCT SLDB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.68 13.82 4.72
Net debt to EBITDA 1.15 1.05 0.96

Dividend

Metric NVCT SLDB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NVCT SLDB Biotechnology median
Market cap 617.95m 615.48m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack